ロード中...
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease–mineral bone disorder parameters in dialysis patients
BACKGROUND: Treatment of hyperphosphataemia is the primary goal of chronic kidney disease–mineral and bone disorder (CKD-MBD) management. This post hoc analysis of a randomized, Phase 3 study evaluated the effects of 1-year treatment with the phosphate binders sucroferric oxyhydroxide or sevelamer c...
保存先:
| 出版年: | Nephrol Dial Transplant |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6603395/ https://ncbi.nlm.nih.gov/pubmed/29846719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfy127 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|